Workflow
6G通感一体化
icon
Search documents
揭秘涨停丨光通信板块多股涨停
Market Overview - A total of 96 stocks in the A-share market hit the daily limit, with 78 stocks after excluding 18 ST stocks, resulting in a limit-up rate of 76.8% [1] Top Performers - LeiKe Defense had the highest limit-up order volume with 632,400 hands, followed by Shida Group, Xinhua Du, and Yingxin Development with 594,000 hands, 440,100 hands, and 371,000 hands respectively [2] - LeiKe Defense has achieved a five-day limit-up streak, while several other stocks, including *ST Suwu and MengTian Home, have also shown strong performance with multiple consecutive limit-ups [2] Sector Highlights Optical Communication - Multiple stocks in the optical communication sector hit the limit, including TeFa Information, FuJing Technology, RuiSiKangDa, ChangFa Optical Fiber, and KeChuan Technology [4] - TeFa Information's project on "Wide Temperature MEMS Optical Fiber Multi-Physical Quantity Sensitive Components and Sensors" has passed the mid-term acceptance by the Ministry of Science and Technology [4] - FuJing Technology's products are primarily used in laser and optical communication fields [5] - RuiSiKangDa focuses on cutting-edge optical communication technologies [6] PCB (Printed Circuit Board) - Stocks such as HuDian Co., ZhongCai Technology, HongHe Technology, and NuoDe Co. also hit the limit [7] - HuDian Co. is investing approximately 4.3 billion yuan in a new project for high-end printed circuit boards, expected to start trial production in the second half of 2026 [7] - ZhongCai Technology has developed a low-dielectric product for high-end PCBs, which has won a domestic technology breakthrough award [8] Pharmaceuticals - Stocks like BeiDa Pharmaceutical, TeYi Pharmaceutical, JinDiKe, Hainan HaiYao, and GuangJi Pharmaceutical saw limit-ups [10] - BeiDa Pharmaceutical focuses on core areas such as anti-infection, pain relief, and chronic disease management [10] - TeYi Pharmaceutical produces children's flu medications [11] - JinDiKe's R&D expenses increased due to the ongoing clinical trials for a quadrivalent influenza vaccine for children [12] Institutional Activity - Institutions net bought over 100 million yuan in stocks like Aerospace Development, GuangKu Technology, and ShengXin Lithium Energy [13] - The top net buying amounts from institutional seats were 147 million yuan for Aerospace Development, 93.9 million yuan for GuoFeng New Materials, and 89.7 million yuan for BeiDa Long [13]